Tailoring oral targeted therapies dosage in lung cancer: A systematic review of pharmacokinetics studies on renal and hepatic impairment.

Tailoring oral targeted therapies dosage in lung cancer: A systematic review of pharmacokinetics studies on renal and hepatic impairment.

Show other versions (1)

<h4>Background</h4>Lung cancer is the leading cause of cancer-related deaths worldwide, and stage IV lung cancer is frequently managed with targeted therapy. Renal and hepatic impairment frequently coexist with cancer, often requiring a reduction in targeted therapy dosage. This systemat...

Full description

Saved in:
Bibliographic Details
Main Authors: Harri Hardi, Zahra Fitrianti, Karen Elliora Utama, Ananda Pipphali Vidya, Nurul Gusti Khatimah, Kevin Aristyo, Hana Khairina Putri Faisal, Vivian Soetikno
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2025-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0324056
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1371/journal.pone.0324056

Similar Items